4B4-92777-58929
2 vaccinations
1 coded response
25 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 232 / VA
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Registered in v-safe
-
2021-03-22
Dose 1 — Pfizer-BioNTech
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-31
- 2021-04-05
-
2021-04-12
Dose 2 — Pfizer-BioNTech
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-19
-
2021-04-26
Survey response — day 14, dose 2MedDRA: Chills, Dizziness, Headache, Pyrexia — Feeling: GoodFree text: I experienced 2.5 days of fever, chills, headache & dizziness.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-05
- 2021-05-10
- 2021-05-19
- 2021-05-24
- 2021-07-12
- 2021-10-11
- 2022-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Pfizer-BioNTech | |
| 2 | 2021-04-12 | Pfizer-BioNTech |
Free text
Release 8 — day 14, dose 2
Symptoms: I experienced 2.5 days of fever, chills, headache & dizziness.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release